Literature DB >> 3154727

The dacryolithiasis syndrome.

M J Hawes1.   

Abstract

A syndrome of the typical patient with a dacryolith in the lacrimal sac or nasolacrimal duct is described, based on review of 107 consecutive patients undergoing dacryocystorhinostomy (DCR) and 43 patients with a history of dacryocystitis. The incidence of dacryolithiasis was 14% of all patients having a DCR. The typical patient with a dacryolith was 45 years old, had a 4.8 year history of intermittent epiphora, had at least one episode of acute dacryocystitis, and could be irrigated with some fluid getting into the nasopharynx. Patients undergoing DCR with a history of acute dacryocystitis had a nine times higher likelihood of having a dacryolith than DCR patients without a history of acute dacryocystitis. DCR was curative in all 15 patients with a dacryolith.

Entities:  

Mesh:

Year:  1988        PMID: 3154727     DOI: 10.1097/00002341-198804020-00005

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  4 in total

1.  TFF peptides and mucins are major components of dacryoliths.

Authors:  Friedrich P Paulsen; Ulrich Schaudig; Alexander Fabian; Dirk Ehrich; Saadettin Sel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-02       Impact factor: 3.117

2.  Lacrimal sac dacryolith (76 cases): a predictive factor for successful endonasal dacryocystorhinostomy?

Authors:  Pavel Komínek; Stanislav Červenka; Karol Zeleník; Tomáš Pniak; Hana Tomášková; Petr Matoušek
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-26       Impact factor: 2.503

3.  Clinicopathological features of dacryolithiasis in Japanese patients: frequent association with infection in aged patients.

Authors:  Masabumi Kubo; Tomoki Sakuraba; Ryuichi Wada
Journal:  ISRN Ophthalmol       Date:  2013-09-02

4.  Clinical features and surgical outcomes of primary canaliculitis with concretions.

Authors:  Shengjin Xiang; Bin Lin; Qintuo Pan; Meiqin Zheng; Xiaoyi Qin; Youpei Wang; Zongduan Zhang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.